Video

Q&A With Mary Norine Walsh From St. Vincent Hospital: New Therapies Provide Hope for Heart Failure Patients

Author(s):

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

With the introduction of two new medications cardiologists have powerful new tools to use in order to help heart failure become an even more manageable condition.

Mary Norine Walsh, MD, from St. Vincent Hospital in Indianapolis discussed these new options as well as other areas of interest for the condition during the European Society of Cardiology's annual conference in London. In addition to her duties at the hospital Walsh also serves as the Vice President of the American College of Cardiology.

Whether it is the general practitioner, the cardiologist, or the cardiac surgeon, the landscape of heart failure treatment is constantly changing. Because of this learning remains an important factor in daily practice.

New medications and treatments for heart failure have been developed over the past couple of decades but there is still more work to be done. This includes improving existing technology and also adding new tools in the fight against the condition.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.